Wuhu Kangqi Pharmaceutical Co., Ltd. is situated in beautiful and fertile Wuhu City of Anhui Province, in northwestern Yangtze River Delta, in the center of East China. The company enjoys convenient transportation and superior geographic location. Wuhu is an important comprehensive transportation terminal of China, with the fifth largest port along the Yangtze River in Wuhu, and the largest wharf for foreign trade in Anhui Province.
Kangqi Pharmaceutical Factory was formerly known as state-owned Wuhu Yangtzer River Pharmaceutical Factory which was founded in 1954. In 2000, Mr. Fang Guilin and shareholders restructured Wuhu Yangtze River Pharmaceutical Co., Ltd. and acquired all varieties and technologies and some devices of Wuhu Yangtze River Pharmaceutical Co., Ltd. and retained technical group and management team, and established Wuhu Kangqi Pharmaceutical Co., Ltd. In 2002, Kangqi Pharmaceutical was officially founded in Wuhu High-tech Industrial Development Zone. The company occupies an area about 47,000 square meters, with plant building area of about 30,000 square meters. There are over 400 employees in the company, more than 100 of whom are doctors, masters, senior engineers, licensed pharmacists, and professional technicians, and more than 60 are QA and QC personnel.
The company adheres to the philosophy of protecting human health, insists on tenet of quality first, credit first, and service first. Under the guidance of chairman Fang Guilin, Kangqi has developed into a large private company that engages in R&D, production, sales and foreign trade.
At the end of 2002, Kangqi passed the State Food and Drug Administration GMP certification and at the end of 2007, it passed the State Food and Drug Administration GMP re-authentication. In June 2012, the company purchased three washing, drying, and filling production lines of small-volume injection. In March 2013, the company passed the GMP certification 2010 edition. It is capable of producing injection products through processes such as concentrated solution, diluted solution, bottle washing, bottle drying, sterilization, lamp examination, lettering, packing, and etc. In August, the company introduced one set of Agilent and Shimadzu high performance liquid analyzer. In April 2016, Kangqi purchased solid preparation production line. It is capable of producing solid preparations through processes such as grinding, sieving, mixing, pelleting, drying, tabletting, coating, bottling, and etc. For years’ effort, "Yangtze River" brand has become famous trademark of China, and it is renowned at home and abroad. in the field of injection, Kangqi has become the most powerful manufacturer with the most complete varieties and specifications in Eastern China. At present, the company has established sales networks and marketing departments in 24 provinces and cities in China. As to marketing strategy, the company insists on the synchronous development of domestic and foreign trade, domestic sales of the company is about 60%, and foreign sales is about 40%. Our products are mainly sold to East Europe, South America, Africa, Middle East, and Southeast Asia. At present, we have drug registration in nearly 20 countries and regions. In recent, the company has established close strategic cooperation relation with Nanjing AngGu Pharmaceutical Technology Co., Ltd. Four varieties of new drugs have passed national examination and are being used in clinical trials.
The company is people-oriented. It takes high and new technology as guidance, regard innovation as soul, and it pays attention to introduction and cultivation of high-quality talents. At present, it has reached cooperation intentions with several well-known advanced medical colleges to offer them comprehensive base for education, scientific research, practice, and employment and in order to improve technological level and quality of company staffs.
Based on advanced production level and strict quality assurance, Kangqi was rated as "professional, exquisite, special, and new” " middle and small-sized enterprises by Economic & Information Commission of Anhui Province in November 2007 and as "double excellence enterprise for drug production management and benefit" by Anhui Food and Drug Administration in March 2008. In November 2008, Kangqi was evaluated as Anhui high-tech enterprise by Anhui Provincial Department of Science and Technology, Department of Finance of Anhui Province, Anhui Municipal Office, SAT and Anhui Local Taxation Bureau. In March 2009, the company was evaluated as "AA rating drug safety and credit enterprise" by Wuhu Municipal Food and Drug Administration. In 2012, the company was identified as innovation pilot enterprise by the People's Government of Anhui Province. Kangqi has won honors such as "national high-tech enterprise", "AAA rating credit enterprise", "valuing credit and observing contract enterprise", "AA rating credit unit for drug production", "private enterprise and big tax-payer", and etc. Kangqi has 21 utility model patents, 37 design patents, 20 exclusive rights to use trademark, and 156 domestic drug approval numbers.
Modern Chinese medicines are manufactured with modern high and new technologies according to international standard. We strive to realize modernization, internationalization, and industrialization of Chinese tradition medicine in five years. We would like to cooperate with you based on high-quality products, competitive prices, and sincere services!